Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000976949 | SCV001124859 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2022-02-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029996 | SCV001180122 | likely benign | Nephrolithiasis/nephrocalcinosis | 2018-12-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003387949 | SCV004100009 | likely benign | not specified | 2023-09-20 | criteria provided, single submitter | clinical testing |